{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T01:01:45Z","timestamp":1778720505262,"version":"3.51.4"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2012,6,26]],"date-time":"2012-06-26T00:00:00Z","timestamp":1340668800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1007\/s10792-012-9599-0","type":"journal-article","created":{"date-parts":[[2012,6,26]],"date-time":"2012-06-26T00:34:33Z","timestamp":1340670873000},"page":"539-545","source":"Crossref","is-referenced-by-count":11,"title":["Clinical manifestation and prognosis of active ocular toxoplasmosis in Iran"],"prefix":"10.1007","volume":"32","author":[{"given":"Farzan","family":"Kianersi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Afsaneh","family":"Naderi Beni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zahra","family":"Naderi Beni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,6,26]]},"reference":[{"key":"9599_CR1","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1136\/bjo.82.9.1017","volume":"82","author":"RM Whittle","year":"1998","unstructured":"Whittle RM, Wallace GR, Whiston RA, Dumondea DC, Stanfordb MR et al (1998) Human antiretinal antibodies in toxoplasma retinochoroiditis. Br J Ophthalmol 82:1017\u20131021","journal-title":"Br J Ophthalmol"},{"key":"9599_CR2","first-page":"385","volume-title":"Diagnosis and treatment of uveitis","author":"AP Mata Da","year":"2002","unstructured":"Da Mata AP, Orefice F (2002) Toxoplasmosis. In: Foster S, Vitale A (eds) Diagnosis and treatment of uveitis. Saunders, Philadelphia, pp 385\u2013410"},{"key":"9599_CR3","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/BF02306486","volume":"13","author":"JG Koppe","year":"1989","unstructured":"Koppe JG, Rothova A (1989) Congenital toxoplasmosis: a long term follow up of 20\u00a0years. Int Ophthalmol 13:387\u2013390","journal-title":"Int Ophthalmol"},{"key":"9599_CR4","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1542\/peds.66.5.767","volume":"66","author":"CB Wilson","year":"1980","unstructured":"Wilson CB, Remington JS, Stagno S, Reynolds DW (1980) Development of adverse sequelae in children born with subclinical congenital toxoplasma infection. Pediatrics 66:767\u2013774","journal-title":"Pediatrics"},{"key":"9599_CR5","first-page":"351","volume-title":"Handbook of clinical neurology. Microbial disease","author":"J Courvreur","year":"1988","unstructured":"Courvreur J, Desmonts G (1988) Acquired and congenital toxoplasmosis. In: Harris AA (ed) Handbook of clinical neurology. Microbial disease, vol 8. Elsevier, Amsterdam, pp 351\u2013363"},{"key":"9599_CR6","first-page":"1183","volume-title":"Ocular infection and immunity","author":"GN Holland","year":"1996","unstructured":"Holland GN, O\u2019Connor GR, Belfort R Jr, Remington JS (1996) Toxoplasmosis. In: Pepose JS, Holland GN, Wilhelmus KR (eds) Ocular infection and immunity. Mosby Yearbook, St Louis, pp 1183\u20131223"},{"key":"9599_CR7","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1038\/eye.2008.219","volume":"23","author":"A de-la-Torre","year":"2009","unstructured":"de-la-Torre A, L\u00f3pez-Castillo CA, G\u00f3mez-Mar\u00edn JE (2009) Incidence and clinical characteristics in a Colombian cohort of ocular toxoplasmosis. Eye 23:1090\u20131093","journal-title":"Eye"},{"key":"9599_CR8","first-page":"1249","volume-title":"Principles and practice of ophthalmology: clinical practice","author":"C Kupfer","year":"1994","unstructured":"Kupfer C, Underwood B, Gillen T (1994) Leading causes of visual impairment worldwide. In: Albert DM, Jakobiec FA (eds) Principles and practice of ophthalmology: clinical practice. Saunders, Philadelphia, pp 1249\u20131255"},{"key":"9599_CR9","first-page":"2","volume":"6","author":"DDM McGavin","year":"1993","unstructured":"McGavin DDM (1993) The world health organization categories of visual impairment. Commun Eye Health 6:2","journal-title":"Commun Eye Health"},{"key":"9599_CR10","first-page":"115","volume":"73","author":"B Thylefors","year":"1995","unstructured":"Thylefors B, Negrel AD, Pararajasegaram R, Dadzie KY (1995) Global data on blindness. Bull World Health Organ 73:115\u2013121","journal-title":"Bull World Health Organ"},{"key":"9599_CR11","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1001\/archopht.1969.00990010483005","volume":"81","author":"CT Friedmann","year":"1969","unstructured":"Friedmann CT, Knox DL (1969) Variations in recurrent active toxoplasmic retinochoroiditis. Arch Ophthalmol 81:481\u2013493","journal-title":"Arch Ophthalmol"},{"key":"9599_CR12","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1017\/S0950268899002800","volume":"123","author":"RE Gilbert","year":"1999","unstructured":"Gilbert RE, Dunn DT, Lightman S, Murray PI, Pavesio CE, Gormley PD, Masters J, Parker SP, Stanford MR (1999) Incidence of symptomatic toxoplasma eye disease: aetiology and public health implications. Epidemiol Infect 123:283\u2013289","journal-title":"Epidemiol Infect"},{"key":"9599_CR13","first-page":"192","volume":"50","author":"GR O\u2019Connor","year":"1974","unstructured":"O\u2019Connor GR (1974) Manifestations and management of ocular toxoplasmosis. Bull NY Acad Med 50:192\u2013210","journal-title":"Bull NY Acad Med"},{"key":"9599_CR14","doi-asserted-by":"crossref","unstructured":"Rothova A (1993) Ocular involvement in toxoplasmosis [published erratum appears in Br J Ophthalmol 1993;77:683] [review]. Br J Ophthalmol 77:371\u20137","DOI":"10.1136\/bjo.77.6.371"},{"issue":"1","key":"9599_CR15","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3347\/kjp.2009.47.1.61","volume":"47","author":"A Salahi-Moghaddam","year":"2009","unstructured":"Salahi-Moghaddam A, Hafizi A (2009) A serological study on toxoplasma gondii infection among people in south of Tehran. Iran Korean J Parasitol 47(1):61\u201363","journal-title":"Iran Korean J Parasitol"},{"issue":"6","key":"9599_CR16","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.ajo.2008.09.006","volume":"146","author":"EM Dodds","year":"2008","unstructured":"Dodds EM, Holland GN, Stanford MR, Yu F, Siu WO, Shah KH, Ten Dam-van Loon N, Muccioli C, Hovakimyan A, Barisani-Asenbauer T, International Ocular Toxoplasmosis Research Group (2008) Intraocular inflammation associated with ocular toxoplasmosis: relationships at initial examination. Am J Ophthalmol 146(6):856\u2013865","journal-title":"Am J Ophthalmol"},{"key":"9599_CR17","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1093\/clinids\/23.2.277","volume":"23","author":"JG Montoya","year":"1996","unstructured":"Montoya JG, Remington JS (1996) Toxoplasmic chorioretinitis in the setting of acute acquired toxoplasmosis. Clin Infect Dis 23:277\u2013282","journal-title":"Clin Infect Dis"},{"key":"9599_CR18","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S0161-6420(97)30362-5","volume":"104","author":"MW Johnson","year":"1997","unstructured":"Johnson MW, Greven CM, Jaffe GJ, Sudhalker H, Vine AK (1997) Atypical, severe toxoplasmic retinochoroiditis in elderly patients. Ophthalmology 104:48\u201357","journal-title":"Ophthalmology"},{"issue":"2","key":"9599_CR19","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1590\/S0037-86822009000200014","volume":"42","author":"AL Aleixo","year":"2009","unstructured":"Aleixo AL, Benchimol EI, Neves Ede S, Silva CS, Coura LC, Amendoeira MR (2009) Frequency of lesions suggestive of ocular toxoplasmosis among a rural population in the State of Rio de Janeiro. Rev Soc Bras Med Trop 42(2):165\u2013169","journal-title":"Rev Soc Bras Med Trop"},{"key":"9599_CR20","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1016\/j.ophtha.2005.05.025","volume":"112","author":"M Soheilian","year":"2005","unstructured":"Soheilian M, Sadoughi MM, Ghajarnia M, Dehghan MH, Yazdani S, Behboudi H, Anisian A (2005) Prospective randomized trial of trimethoprim\/sulfamethoxazole versus pyrimethamine and sulfadiazine in the treatment of ocular toxoplasmosis. Ophthalmology 112:1876\u20131882","journal-title":"Ophthalmology"},{"key":"9599_CR21","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1590\/S0074-02762000000100014","volume":"95","author":"JE Gomez-Marin","year":"2000","unstructured":"Gomez-Marin JE, Montoya-De-Londono MT, Castano-Osorio JC, Heine FA, Duque AM, Chemla C, Aubert D, Bonhomme A, Pinon JM (2000) Frequency of specific anti-Toxoplasma gondii IgM, IgA and IgE in Colombian patients with acute and chronic ocular toxoplasmosis. Mem Inst Oswaldo Cruz 95:89\u201394","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"9599_CR22","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/S0140-6736(86)90785-3","volume":"1","author":"JG Koppe","year":"1986","unstructured":"Koppe JG, Loewer-Sieger DH, De Roever-Bonnet H (1986) Results of 20-year follow-up of congenital toxoplasmosis. Lancet 1:254\u2013256","journal-title":"Lancet"},{"key":"9599_CR23","first-page":"11","volume":"95","author":"N Roizen","year":"1995","unstructured":"Roizen N, Swisher CN, Stein MA, Hopkins J, Boyer KM, Holfels E, Mets MB (1995) Neurologic and developmental outcome in treated congenital toxoplasmosis. Pediatrics 95:11\u201320","journal-title":"Pediatrics"},{"issue":"5","key":"9599_CR24","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1177\/112067210901900522","volume":"19","author":"M Accorinti","year":"2009","unstructured":"Accorinti M, Bruscolini A, Pirraglia MP, Liverani M, Caggiano C (2009) Toxoplasmic retinochoroiditis in an Italian referral center. Eur J Ophthakmol 19(5):824\u2013830","journal-title":"Eur J Ophthakmol"},{"issue":"2","key":"9599_CR25","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/IIO.0b013e3181d26bf4","volume":"50","author":"JF Arevalo","year":"2010","unstructured":"Arevalo JF, Belfort R Jr, Muccioli C, Espinoza JV (2010) Ocular toxoplasmosis in the developing world. Int Ophthalmol Clin 50(2):57\u201369","journal-title":"Int Ophthalmol Clin"},{"key":"9599_CR26","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1007\/s10384-003-0069-0","volume":"48","author":"LS Atmaca","year":"2004","unstructured":"Atmaca LS, Simsek T, Batioglu F (2004) Clinical features and prognosis in ocular toxoplasmosis. Jpn J Ophthalmol 48:386\u2013391","journal-title":"Jpn J Ophthalmol"},{"key":"9599_CR27","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/j.1755-3768.1977.tb06132.x","volume":"55","author":"M Saari","year":"1977","unstructured":"Saari M (1977) Toxoplasmic chorioretinitis affecting the macula. Acta Ophthalmol (Copenh) 55:539\u2013547","journal-title":"Acta Ophthalmol (Copenh)"},{"key":"9599_CR28","first-page":"935","volume":"6","author":"MJ Hogan","year":"1961","unstructured":"Hogan MJ (1961) Ocular toxoplasmosis in adult patients. Surv Ophthalmol 6:935\u2013951","journal-title":"Surv Ophthalmol"},{"key":"9599_CR29","first-page":"283","volume-title":"Recent advances in uveitis: proceedings of the third international symposium on uveitis","author":"J Melamed","year":"1993","unstructured":"Melamed J (1993) Clinical appearance of toxoplasmic retinochoroiditis. In: Dernouchamps JP, Verougstraete C, Caspers-Velu L, Tassignon MJ (eds) Recent advances in uveitis: proceedings of the third international symposium on uveitis. Kugler Publications, New York, pp 283\u2013288"},{"key":"9599_CR30","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1136\/bmj.310.6986.1037","volume":"310","author":"RE Gilbert","year":"1995","unstructured":"Gilbert RE, Stanford MR, Jackson H, Holliman RE, Sanders MD (1995) Incidence of acute symptomatic toxoplasma retinochoroiditis in south London according to country of birth. BMJ 310:1037\u20131040","journal-title":"BMJ"},{"issue":"12","key":"9599_CR31","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1001\/archopht.1995.01100120054009","volume":"113","author":"MJH Ronday","year":"1995","unstructured":"Ronday MJH, Luyendijk L, Baarsma GS, Bollemeijer J-G, Van der Lelij A, Rothova A (1995) Presumed acquired ocular toxoplasmosis. Arch Ophthalmol 113(12):1524\u20131529","journal-title":"Arch Ophthalmol"},{"issue":"2","key":"9599_CR32","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1136\/bjo.2006.100925","volume":"91","author":"J Scherrer","year":"2007","unstructured":"Scherrer J, Iliev ME, Halberstadt M, Kodjikian L, Garweg JG (2007) Visual function in human ocular toxoplasmosis. Br J Ophthalmol 91(2):233\u2013236","journal-title":"Br J Ophthalmol"},{"key":"9599_CR33","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1001\/archopht.1988.01060130810028","volume":"106","author":"JR Rehder","year":"1988","unstructured":"Rehder JR, Burnier MB Jr, Pavesio CE, Kim MK, Rigueiro M, Petrilli AM, Belfort R Jr (1988) Acute unilateral toxoplasmic iridocyclitis in an AIDS patient. Am J Ophthalmol 106:740\u2013741","journal-title":"Am J Ophthalmol"},{"key":"9599_CR34","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/00006982-199901000-00004","volume":"19","author":"C Auer","year":"1999","unstructured":"Auer C, Bernasconi O, Herbort CP (1999) Indocyanine green angiography features in toxoplasmic retinochoroiditis. Retina 19:22\u201329","journal-title":"Retina"},{"key":"9599_CR35","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/S0161-6420(02)00990-9","volume":"109","author":"L Bosch-Driessen","year":"2002","unstructured":"Bosch-Driessen L, Berendscho T, Ongkosuwito JV, Rothova A (2002) Ocular toxoplasmosis: clinical features and prognosis of 154 patients. Ophthalmology 109:869\u2013878","journal-title":"Ophthalmology"},{"key":"9599_CR36","first-page":"16","volume":"12","author":"AG Spaulding","year":"1967","unstructured":"Spaulding AG, Font RL (1967) Acquired toxoplasmic chorioretinitis. Surv Ophthalmol 12:16\u201323","journal-title":"Surv Ophthalmol"},{"key":"9599_CR37","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S0161-6420(99)00013-5","volume":"I07","author":"LH Bosch-Driessen","year":"2000","unstructured":"Bosch-Driessen LH, Karimi S, Stilma JS, Rothova A (2000) Retinal detachment in ocular toxoplasmosis. Ophthalmology I07:36\u201340","journal-title":"Ophthalmology"},{"key":"9599_CR38","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/BF02306491","volume":"13","author":"A Rothova","year":"1989","unstructured":"Rothova A, Buitenhuis HJ, Meenken C, Baarsma GS, Boen-Tan TN, de Jong PT, Schweitzer CM, Timmerman Z, de Vries J, Zaal MJ (1989) Therapy of ocular toxoplasmosis. Int Ophthalmol 13:415\u2013419","journal-title":"Int Ophthalmol"},{"key":"9599_CR39","first-page":"15","volume":"10","author":"JC Timsit","year":"1987","unstructured":"Timsit JC, Bloch-Michel E (1987) Efficacy of specific chemotherapy in the prevention of recurrences of toxoplasmic chorioretinitis during the 4\u00a0years following treatment. J Fr Ophtalmol 10:15\u201323","journal-title":"J Fr Ophtalmol"},{"key":"9599_CR40","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1001\/archopht.1962.00960020712004","volume":"67","author":"RV Fajardo","year":"1962","unstructured":"Fajardo RV, Furgiuele FP, Leopold IH (1962) Treatment of toxoplasmosis uveitis. Arch Ophthalmol 67:712\u2013720","journal-title":"Arch Ophthalmol"},{"key":"9599_CR41","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/0002-9394(83)90378-1","volume":"95","author":"V Lakhanpal","year":"1983","unstructured":"Lakhanpal V, Schocket SS, Nirankari VS (1983) Clindamycin in the treatment of toxoplasmic retinochoroiditis. Am J Ophthalmol 95:605\u2013613","journal-title":"Am J Ophthalmol"},{"key":"9599_CR42","first-page":"58","volume":"28","author":"S Lam","year":"1993","unstructured":"Lam S, Tessler HH (1993) Quadruple therapy for ocular toxoplasmosis. Can J Ophthalmol 28:58\u201361","journal-title":"Can J Ophthalmol"},{"key":"9599_CR43","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/0002-9394(63)90387-8","volume":"55","author":"CJ Canamucio","year":"1963","unstructured":"Canamucio CJ, Hallett JW, Leopold IH (1963) Recurrence of treated toxoplasmic uveitis. Am J Ophthalmol 55:1035\u20131039","journal-title":"Am J Ophthalmol"},{"key":"9599_CR44","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1755-3768.1983.tb01394.x","volume":"61","author":"H Guldsten","year":"1983","unstructured":"Guldsten H (1983) Clindamycin and sulphonamides in the treatment of ocular toxoplasmosis. Acta Ophthalmol (Copenh) 61:51\u201357","journal-title":"Acta Ophthalmol (Copenh)"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-012-9599-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10792-012-9599-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-012-9599-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,19]],"date-time":"2022-01-19T14:13:21Z","timestamp":1642601601000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10792-012-9599-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6,26]]},"references-count":44,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["9599"],"URL":"https:\/\/doi.org\/10.1007\/s10792-012-9599-0","relation":{},"ISSN":["0165-5701","1573-2630"],"issn-type":[{"value":"0165-5701","type":"print"},{"value":"1573-2630","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,6,26]]}}}